Wednesday, July 8, 2026

Drug profile · INN

perfluoropolymethylisopropyl ether

perfluoropolymethylisopropyl ether (SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — perfluoropolymethylisopropyl ether
US status
approved
Class
Route
TOPICAL
Patents
0
Programs
3
Data quality
0.84

Quick answer

perfluoropolymethylisopropyl ether (SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN perfluoropolymethylisopropyl ether
Brand SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS
Route TOPICAL
Formulation PASTE

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Exposure to sporting events Phase 1 · Chinese Academy of · Coronary Heart Disease
  2. Rosuvastatin Approved · First People's Hospital · Hyperlipidemia
  3. Reduction CTVp1 Unknown · Chinese Academy of · Nasopharyngeal Carcinoma

Frequently asked questions

What is perfluoropolymethylisopropyl ether?

perfluoropolymethylisopropyl ether (SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for perfluoropolymethylisopropyl ether?

SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS is a marketed brand name for perfluoropolymethylisopropyl ether. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of perfluoropolymethylisopropyl ether?

perfluoropolymethylisopropyl ether has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.